EMEA-002268-PIP02-18-M01 - paediatric investigation plan
Niraparib (tosilate monohydrate)
PIPHuman
GlaxoSmithKline (Ireland) Limited
E-mail: eu.paediatric-plans@gsk.com
Tel: +1 4388998201
P/0184/2021 : EMA decision of 10 May 2021 on the acceptance of a modification of an agreed paediatric investigation plan for niraparib (tosylate monohydrate), (Zejula), (EMEA-002268-PIP02-18-M01)